热门资讯> 正文
Senti Biosciences将实施1比10的反向股票拆分以满足纳斯达克合规
2024-07-16 20:50
- Biotechnology company Senti Biosciences (NASDAQ:SNTI) said on Tuesday that it will effect a 1-for-10 reverse stock split to regain compliance with Nasdaq rules.
- The company's board approved a 1-for-10 reverse stock split, effective July 17 11:59 PM EDT.
- SNTI shares were trading -0.03% pre-market.
- The new CUSIP number will be 81726A209.
- The reverse stock split will reduce the company's outstanding shares to ~4.6M from ~45.8M.
- The move comes in the wake of Nasdaq notifying Senti Bio of non-compliance with the stock exchange's minimum bid price requirement.
- Source: Press Release
More on Senti Biosciences
- Financial information for Senti Biosciences
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
